Skip to main content
. 2016 Nov 10;12(6):5043–5051. doi: 10.3892/ol.2016.5375

Figure 9.

Figure 9.

Shift in therapeutic regimen in the second line between 2008 and 2011. Pts., patients; A(I), Adriamycin or idarubicin; VA(I)D(P), vincristine, Adriamycin or idarubicin, dexamethasone or prednisone; P/D, prednisone or dexamethasone.